| # | Drug | Count |
|---|---|---|
| 0 | CETUXIMAB | 11 |
| 1 | FLUOROURACIL | 11 |
| 2 | FLUOROURACIL CREAM, 0.5% | 11 |
| 3 | LEUCOVORIN CALCIUM | 10 |
| 4 | IRINOTECAN HYDROCHLORIDE | 8 |
| 5 | PIPERACILLIN SODIUM,TAZOBACTAM SODIUM | 3 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | IRINOTECAN HYDROCHLORIDE | 8 | 0.0006 |
| 1 | LEUCOVORIN CALCIUM | 10 | 0.0005 |
| 2 | CETUXIMAB | 11 | 0.0003 |
| 3 | FLUOROURACIL CREAM, 0.5% | 11 | 0.0001 |
| 4 | FLUOROURACIL | 11 | 0.0001 |
| 5 | PIPERACILLIN SODIUM,TAZOBACTAM SODIUM | 3 | 0.0001 |
| # | Drug class | Count |
|---|---|---|
| 0 | Epidermal Growth Factor Receptor Antagonist [EPC] | 11 |
| 1 | Nucleoside Metabolic Inhibitor [EPC] | 11 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Epidermal Growth Factor Receptor Antagonist [EPC] | 11 | 0.0002 |
| 1 | Nucleoside Metabolic Inhibitor [EPC] | 11 | 0.0000 |